Managing multiple Claude Code projects doesn't have to be chaotic. My iTerm2 setup dramatically reduces friction in my daily ...

Landmark, third-party research strengthens evidence of long-term impact beyond a single Girls on the Run season. CHARLOTTE, NC, UNITED STATES, March 25, 2026 ...

The Army will kick off its new retention bonus system next month, using physical fitness scores, technical expertise and commander evaluations to determine a soldier’s payout to reenlist. “We were ...

CHARLESTON — A nonprofit run by City Councilman Aaron Polkey, who was sworn in last month, is set to receive nearly $240,000 from the city for a homeless program. Polkey, president and CEO of Palmetto ...

When students talk about the ability to take Running Start courses during the summer, they don’t talk about credits; they talk about opportunity. For one high school student, enrolling in a summer ...

Social Security, which provides benefits to about 70 million Americans, could run out of money sooner than expected, according to a new report from the Congressional Budget Office. The Old-Age and ...

What just happened? Microsoft has announced several changes and enhancements coming to its official app store. The Microsoft Store can now provide additional app usage and health data, and there is a ...

The Mission Command Training Program (MCTP) is the U.S. Army’s premier deployable Combat Training Center (CTC) that is Chief of Staff of the Army (CSA) directed. Team MCTP consists of four operations ...

Microsoft has announced the Store CLI, a command-line interface for managing and installing Windows apps from the Microsoft Store. It's similar to WinGet, except the Store CLI only works for apps that ...

TURKU, Finland, Feb. 10, 2026 /PRNewswire/ -- Vaadin, the leading provider of Java web application frameworks, today announced the general availability of Swing Modernization Toolkit, a solution that ...

Amgen has terminated its rocatinlimab collaboration with Kyowa Kirin, walking away from the anti-OX40 antibody five years after paying $400 million for rights to the autoimmune disease drug candidate.